Readers And Tweeters Revisit Surgery Centers, Think Twice About Single-Payer
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Search
Filter
6,641 - 6,660 of 15,455 Results
-
-
Tuition-Free Med School Touches Off Multimillion-Dollar Debate
NYU’s promise to help keep medical students debt-free generates joy on campus. But critics question whether it is the best way to recruit a more diverse student pool or get young doctors to commit to primary care.
By Julie Rovner -
Medicaid Covers Foster Kids, But Daunting Health Needs Still Slip Through The Cracks
Nearly all children in the foster care system are covered by Medicaid. Yet, foster parents still struggle to meet the extraordinary health needs of their children. To solve this, some states are experimenting with a coordinated approach to care — with mixed results.
-
Podcast: KHN’s ‘What The Health?’ Opioids, EpiPens And Health Funding
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico discuss Senate action on health funding and opioid legislation, the state of the individual insurance market and consternation over expiration dates on EpiPens, the self-injected allergy remedy. Also, could an otter with asthma signal a potential public health crisis?
-
A Late-Life Surprise: Taking Care Of Frail, Aging Parents
More and more older adults, age 60 and older, care for their elderly parents and face physical, emotional and financial stress.
-
A Black Eye For Blue Shield: Consumers Lash Out Over Coverage Lapses
California’s third-largest insurer faces anger from customers in the individual market who unexpectedly lost their insurance despite paying premiums faithfully. In its recently filed lawsuit, the company blamed a contractor for “egregious” billing problems.
By Chad Terhune -
Religious Conservatives’ Ties To Trump Officials Pay Off In AIDS Policies, Funding
Shepherd Smith, a strong supporter of abstinence-only sex education for AIDS, has been close to the new director of the CDC for decades. This connection is just one example of the "new in crowd" surrounding the Trump administration, where politics and religion mix.
-
Battle Lines Drawn As Abortion-Rights Activists Leave Their Mark Outside Clinics
Armed with poster board and catchy advertising slogans, abortion-rights activists in California and elsewhere are taking to sidewalks, buses and mobile phone apps to fight a recent U.S. Supreme Court ruling in favor of crisis pregnancy centers.
-
Rehabilitation Plus Rehab? Jails Dispense Drugs To Treat Inmates’ Addictions
Rather than go cold turkey, inmates increasingly have the option to take medication to help beat addiction to opioids and other substances. But some warn these substitute drugs serve as another crutch — and a costly one at that.
By Anna Gorman -
Biorhythms And Birth Control: FDA Stirs Debate By Approving ‘Natural’ App
Critics worry about the message federal officials are sending by approving a new birth control option, which uses a mobile phone app for women to track their body temperature and menstrual cycle to avoid pregnancy. But the more choices the better, some reproductive health experts say.
-
The Man Who Sold America On Vitamin D — And Profited In The Process
The doctor most responsible for turning the sunshine supplement into a billion-dollar juggernaut has received hundreds of thousands of dollars from the vitamin D industry, according to government records and interviews.
By Liz Szabo -
Babies Dependent On Opioids Need Touch, Not Tech
One doctor in Kansas works to make sure every hospital in the state can provide the soft start, ideally with their mothers, that babies with neonatal abstinence syndrome need.
-
Hospitals Battle For Control Over Fast-Growing Heart-Valve Procedure
Medicare limits payments for valve replacement via a catheter to hospitals with large numbers of heart procedures. But smaller facilities are crying foul.
-
Purdue Pharma’s Sales Pitch Downplayed Risks Of Opioid Addiction
Through a widely circulated brochure and a videotape of testimonials, the maker of OxyContin stressed patients’ right to opioid treatment for pain.
By Fred Schulte -
Podcast: KHN’s ‘What The Health?’ See You In Court!
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner talk about a spate of lawsuits involving the Affordable Care Act, as well as the latest in state and federal efforts regarding the Medicaid program for the poor.
-
Shortage Of Insurance Fraud Cops Sparks Campaign Debate
About a quarter of fraud investigator positions at the state Department of Insurance are open, and Steve Poizner has made the vacancies a focus of his campaign for insurance commissioner. His opponent, Ricardo Lara, says chasing criminals isn’t the only solution to rising health care costs.
-
Energy-Hog Hospitals: When They Start Thinking Green, They See Green
Some hospitals have taken steps to be more energy-efficient. Though at times these changes barely represent rounding errors in their budgets, comprehensive efforts are beginning to make a difference.
-
Financial Ties That Bind: Studies Often Fall Short On Conflict-Of-Interest Disclosures
A new study in JAMA Surgery finds that a large sample of published medical research failed to disclose details on the financial relationships between medical device makers and physicians. Changes in the disclosure process could close this loop.
By Rachel Bluth -
Listen: Why Young Doctors Appear To Be Embracing Single-Payer
KHN's Shefali Luthra talks about how the American Medical Association's student caucus managed to push the overall organization to begin reviewing and possibly — eventually — reconsider its decades-long opposition to single-payer health care.
-
States Leverage Federal Funds To Help Insurers Lower Premiums
Even as it chips away at Obamacare, the Trump administration is solidly behind state-based initiatives to cover high-cost patients, known as “reinsurance” programs. It approved two more last month.